1. Home
  2. ALXO vs COE Comparison

ALXO vs COE Comparison

Compare ALXO & COE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALXO
  • COE
  • Stock Information
  • Founded
  • ALXO 2015
  • COE 2011
  • Country
  • ALXO United States
  • COE Singapore
  • Employees
  • ALXO N/A
  • COE N/A
  • Industry
  • ALXO Biotechnology: Pharmaceutical Preparations
  • COE Other Consumer Services
  • Sector
  • ALXO Health Care
  • COE Real Estate
  • Exchange
  • ALXO Nasdaq
  • COE Nasdaq
  • Market Cap
  • ALXO 76.5M
  • COE 91.4M
  • IPO Year
  • ALXO 2020
  • COE 2016
  • Fundamental
  • Price
  • ALXO $0.55
  • COE $14.73
  • Analyst Decision
  • ALXO Strong Buy
  • COE
  • Analyst Count
  • ALXO 6
  • COE 0
  • Target Price
  • ALXO $4.14
  • COE N/A
  • AVG Volume (30 Days)
  • ALXO 529.8K
  • COE 11.9K
  • Earning Date
  • ALXO 05-08-2025
  • COE 06-11-2025
  • Dividend Yield
  • ALXO N/A
  • COE N/A
  • EPS Growth
  • ALXO N/A
  • COE N/A
  • EPS
  • ALXO N/A
  • COE N/A
  • Revenue
  • ALXO N/A
  • COE $50,692,000.00
  • Revenue This Year
  • ALXO N/A
  • COE N/A
  • Revenue Next Year
  • ALXO N/A
  • COE N/A
  • P/E Ratio
  • ALXO N/A
  • COE N/A
  • Revenue Growth
  • ALXO N/A
  • COE 86.98
  • 52 Week Low
  • ALXO $0.46
  • COE $6.10
  • 52 Week High
  • ALXO $17.83
  • COE $25.70
  • Technical
  • Relative Strength Index (RSI)
  • ALXO 37.26
  • COE 32.97
  • Support Level
  • ALXO $0.46
  • COE $13.60
  • Resistance Level
  • ALXO $0.63
  • COE $22.00
  • Average True Range (ATR)
  • ALXO 0.06
  • COE 1.59
  • MACD
  • ALXO 0.02
  • COE -0.58
  • Stochastic Oscillator
  • ALXO 42.86
  • COE 13.45

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

About COE 51Talk Online Education Group

51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand.

Share on Social Networks: